Publication Results (134)

• «
• 1
• 2
• 3
• 4
• »

• Asthma and chronic obstructive pulmonary disease (COPD) prevalence and health services use in Ontario Métis: a population-based cohort study

  Gershon A, Khan S, Klein-Geltink J, Wilton D, To T, Crighton EJ, Pigeau L, MacQuarrie J, Allard Y, Russell SJ, Henry DA. PLoS One. 2014; 9(4):e95899.

• Trends in socioeconomic status related differences in mortality among people with chronic obstructive pulmonary disease

  Gershon AS, Hwee J, Victor JC, Wilton AS, To T. Ann Am Thorac Soc. 2014; 11(8):1195-202. Epub 2014 Aug 28.

• Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study

  Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, Stephenson AL, Gill SS, Rochon PA. Drugs Aging. 2013; 30(3):183-92. Epub 2013 Feb 1.

• Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study

  Lee TM, Tu K, Wing LL, Gershon AS. NPJ Prim Care Respir Med. 2017; 27(1):34.

• Trends in chronic obstructive pulmonary disease prevalence, incidence, and health services use in younger adults in Ontario, Canada, 2006-2016

  Gershon AS, McGihon RE, Luo J, Blazer AJ, Kendzerska T, To T, Aaron SD. Am J Respir Crit Care Med. 2021; 203(9):1196-9. Epub 2020 Dec 21. DOI: https://doi.org/10.1164/rccm.202006-2495LE

• Trends in non-receipt of recommended chronic obstructive pulmonary disease medication

  Poon M, Pequeno P, Aaron SD, Stanbrook M, Wong H, Cram P, Gershon AS. ERJ Open Res. 2022; 25(2):00584-02021. Epub 2022 Jan 13. DOI: https://doi.org/10.1183/23120541.00584-2021

• Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: a population study of prevalence, incidence and mortality

  Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network. PLoS One. 2017; 12(3):e0173830.

• Smoking and smoking cessation among people with chronic obstructive pulmonary disease (COPD)

  Guanzhang J, Maclagan L, To T, Aaron SD, Yao Z, Gershon AS. Can Respir J Crit Care Sleep Med. 2021; 5:4. Epub 2019 Dec 18. DOI: https://doi.org/10.1080/24745332.2019.1692259

• Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based study

  Vozoris NT, Wang X, Fischer HD, Gershon AS, Bell CM, Gill SS, O'Donnell DE, Austin PC, Stephenson AL, Rochon PA. Br J Clin Pharmacol. 2016; 81(1):161-70. Epub 2015 Sep 3.

• Progression from asthma to chronic obstructive pulmonary disease. Is air pollution a risk factor?

  To T, Zhu J, Larsen K, Simatovic J, Feldman L, Ryckman K, Gershon A, Lougheed MD, Licskai C, Chen H, Villeneuve PJ, Crighton E, Su Y, Sadatsafavi M, Williams D, Carlsten C; Canadian Respiratory Research Network. Am J Respir Crit Care Med. 2016; 194(4):429-38. Epub 2016 Mar 7.

• Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing

  Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD; Canadian Respiratory Research Network. CMAJ. 2017; 189(14):E530-8. Epub 2016 Nov 14.

• Measuring chronic obstructive pulmonary disease (COPD) quality indicators using primary care electronic medical records (EMRs) in Ontario, Canada

  Lee TM, Tu K, Ivers NM, Barnsley J, Gershon AS. Can J Respir Crit Care Sleep Med. 2022; 6(3):169-83. Epub 2021 Jul 9. DOI: https://doi.org/10.1080/24745332.2021.1913079

• Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population based study

  Gershon AS, Wang C, Wilson AS, Raut R, To T. Arch Intern Med. 2010; 170(6):560-5.

• Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study

  Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lancet. 2011; 378(9795):991-6. Epub 2011 Sep 10.

• Quantifying health services use for chronic obstructive pulmonary disease

  Gershon AS, Guan J, Victor JC, Goldstein R, To T. Am J Respir Crit Care Med. 2013; 187(6):596-601. Epub 2013 Jan 17.

• Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based study

  Antoniou T, Yao Z, Camacho X, Mamdani MM, Juurlink DN, Gomes T. Pharmacoepidemiol Drug Saf. 2015; 24(3):256-61. Epub 2015 Feb 5.

• Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study

  Gershon AS, Macdonald EM, Luo J, Austin PC, Gupta S, Sivjee K, Upshur R, Aaron SD. Fam Pract. 2017; 34(6):708-16. Epub 2017 Jul 7.

• Asthma and chronic obstructive pulmonary disease overlap in women: incidence and risk factors

  To T, Zhu J, Gray N, Feldman LY, Villeneuve PJ, Licskai C, Gershon A, Miller AB. Ann Am Thorac Soc. 2018; 15(11):1304-10. Epub 2018 Jul 26.

• Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996–2015: a retrospective population-based cohort study

  Antoniou T, Yao Z, Raboud J, Gershon AS. CMAJ Open. 2020; 8(1):E83-9. Epub 2020 Feb 18. DOI: https://doi.org/10.9778/cmajo.20190028

• Air pollution as a risk factor for incident chronic obstructive pulmonary disease and asthma: a 15-year population-based cohort study

  Shin S, Bai L, Burnett RT, Kwong JC, Hystad P, van Donkelaar A, Lavigne E, Weichenthal S, Copes R, Martin RV, Kopp A, Chen H. Am J Respir Crit Care Med. 2021; 203(9):1138-48. Epub 2020 Nov 4. DOI: https://doi.org/10.1164/rccm.201909-1744OC

• End-of-life strategies among patients with advanced chronic obstructive pulmonary disease

  Gershon AS, Maclagan LC, Luo J, To T, Kendzerska T, Stanbrook MB, Bourbeau J, Etches J, Aaron SD. Am J Respir Crit Care Med. 2018; 198(11):1389-96. Epub 2018 Jun 11.

• Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis

  Yan M, Saxena FE, Calzavara A, Brown KA, Garber G, Gershon AS, Johnstone J, Kumar M, Langford BJ, Lee S, Schwartz KL, Daneman N. CMAJ Open. 2021; 9(2):E576-84. Epub 2021 May 21. DOI: https://doi.org/10.9778/cmajo.20200157

• October 2019

  Infographics

  • Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease
  • Association between physician intensity of antibiotic prescribing and the prescription of benzodiazepines, opioids and proton-pump inhibitors to nursing home residents: a population-based observational study
  • Cardiovascular consequences of obstructive sleep apnea in women: a historical cohort study

  ICES in the News

  • Prevalence of inappropriateness of parenteral vitamin B12 administration in Ontario, Canada

  You may also be interested in...

  • One-year home-time and mortality after thrombolysis compared with nontreated patients in a propensity-matched analysis
  • Prescription synthetic oral cannabinoid use among older adults with chronic obstructive pulmonary disease: a population-based cohort study
  • Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study
  • Association of early-stage breast cancer and subsequent chemotherapy with risk of atrial fibrillation
  • An opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use
  • Emergency department use in people who experience imprisonment in Ontario, Canada
  • Data variability across Canadian administrative health databases: differences in content, coding, and completeness

• Chronic Obstructive Pulmonary Disease in Ontario, 1996/97 to 2014/15

  Gershon AS, Mecredy G, Ratnasingham S. October 2017

• Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome)

  Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS; Canadian Respiratory Research Network. Ann Am Thorac Soc. 2019; 16(1):71-81. Epub 2018 Oct 29.

• Potential barriers to physician follow-up within 7 days of discharge from a chronic obstructive pulmonary disease hospital admission

  Appleton AJ, Lam M, Allen BN, Richard L, Shariff SZ, Gershon AS. Can J Respir Crit Care Sleep Med. 2020; 5(5):283-92. Epub 2020 Aug 18. DOI: https://doi.org/10.1080/24745332.2020.1770637

• Association of palliative care with days at home and healthcare use in patients with advanced chronic obstructive pulmonary disease: a cohort study

  Maclagan LC, Wu F, Liu N, Tanuseputro P, Stukel TA, Guan J, Kendzerska T, Stefan MS, Lindenauer PK, Gershon AS. Ann Am Thorac Soc. 2022; 19(1):48-57. Epub 2021 Jun 25. DOI: https://doi.org/10.1513/AnnalsATS.202007-859OC

• Outpatient antibiotic therapy and short-term mortality in elderly patients with chronic obstructive pulmonary disease

  Sin DD, Tu JV. Can Respir J. 2000; 7(6):466-71.

• Survival with tiotropium compared to long-acting Beta-2-agonists in chronic obstructive pulmonary disease

  Gershon AS, Wang L, To T, Luo J, Upshur RE. COPD. 2008; 5(4):229-34.

• Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study

  Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS. Arch Intern Med. 2011; 171(10):914-20.

• Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study

  Stephenson A, Seitz DP, Fischer HD, Gruneir A, Bell CM, Gershon AS, Fu L, Anderson GM, Austin PC, Rochon PA, Gill SS. Drugs Aging. 2012; 29(3):213-23.

• Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease

  Austin PC, Stanbrook MB, Anderson GM, Newman A, Gershon AS. Ann Epidemiol. 2012; 22(12):881-7. Epub 2012 Nov 1.

• Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease

  Nie JX, Wang L, Upshur RE. Can Respir J. 2007; 14(8):485-9.

• Quantifying comorbidity in individuals with chronic obstructive pulmonary disease: a population study

  Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Eur Respir J. 2015; 45(1):51-9. Epub 2014 Aug 20.

• Incident opioid drug use and adverse respiratory outcomes among older adults with COPD

  Vozoris NT, Wang X, Fischer HD, Bell CM, O'Donnell DE, Austin PC, Stephenson AL, Gill SS, Rochon PA. Eur Respir J. 2016; 48(3):683-93. Epub 2016 Jul 13.

• Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD

  Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, Austin PC, Anderson GM, Bell CM, Gill SS, Rochon PA. Eur Respir J. 2014; 44(2):332-40. Epub 2014 Apr 17.

• Health services burden of undiagnosed and overdiagnosed COPD

  Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network. Chest. 2018; 153(6):1336-46. Epub 2018 Feb 6.

• Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease

  Gershon AS, Chung H, Porter J, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Campigotto A, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor AE, Smieja M, Zahariadis G, Kwong JC. J Infect Dis. 2020; 221(1):42-52. Epub 2019 Sep 24. DOI: https://doi.org/10.1093/infdis/jiz419

• Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients

  Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Am J Respir Crit Care Med. 1997; 155(4):1278-82.

• Predictors of opioid-related adverse pulmonary events among older adults with chronic obstructive pulmonary disease

  Vozoris NT, Pequeno P, Li P, Austin PC, O'Donnell DE, Gershon AS. Ann Am Thorac Soc. 2020; 17(8):965-73. Epub 2020 May 12. DOI: https://doi.org/10.1513/AnnalsATS.201910-760OC

• «
• 1
• 2
• 3
• 4
• »